These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8074561)

  • 1. [Current and future aspects of quinolones].
    Bush V; Dalkhoff A; Tsaĭler KhI
    Antibiot Khimioter; 1993; 38(2-3):3-8. PubMed ID: 8074561
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing quinolone resistance: are the new agents more or less likely to cause resistance?
    Thomson KS
    J Antimicrob Chemother; 2000 Jun; 45(6):719-23. PubMed ID: 10837422
    [No Abstract]   [Full Text] [Related]  

  • 3. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of new fluoroquinolones].
    N'iu GS
    Antibiot Khimioter; 1993; 38(2-3):8-14. PubMed ID: 8074570
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD; Brighty KE
    Med Res Rev; 1996 Sep; 16(5):433-86. PubMed ID: 8865150
    [No Abstract]   [Full Text] [Related]  

  • 6. The place of quinolones in medicine today.
    Oh HM
    Singapore Med J; 1994 Dec; 35(6):562-4. PubMed ID: 7761876
    [No Abstract]   [Full Text] [Related]  

  • 7. Lomefloxacin sensitivities.
    Smith JM; Hashmi ZS
    N Z Med J; 1990 Jun; 103(891):277-8. PubMed ID: 2356052
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of quinolones in the treatment of community acquired pneumonia].
    Garau J
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():31-5. PubMed ID: 9717158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of the fluoroquinolones.
    Scully BE
    Urology; 1990 Jan; 35(1 Suppl):8-10. PubMed ID: 2404373
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbiologic aspects of fluoroquinolones.
    Neu HC
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quinolones.
    Neu HC
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluoroquinolones--current value in antibacterial therapy, outlook for development].
    Navashin SM; Navashin PS
    Antibiot Khimioter; 1996; 41(9):4-10. PubMed ID: 9005784
    [No Abstract]   [Full Text] [Related]  

  • 16. [The present status and future perspectives of fluorinated quinolones from the aspect of clinical microbiology].
    Lochmann O
    Cas Lek Cesk; 1997 Mar; 136(6):191-5. PubMed ID: 9221193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(2):30-9. PubMed ID: 9551171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action and resistance to fluoroquinolones].
    Alarcón T; López-Brea M
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):111-7. PubMed ID: 8714159
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug not considered a first-line agent.
    Lexchin J
    Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of new quinolones against clinical isolates of Corynebacterium species].
    Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
    Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.